2012
DOI: 10.1016/j.reuma.2012.02.010
|View full text |Cite
|
Sign up to set email alerts
|

Terapia biológica: sobrevida y seguridad en padecimientos reumáticos. Resultados del Registro Nacional Biobadamex 1.0

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
3
0

Year Published

2014
2014
2024
2024

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 17 publications
(3 citation statements)
references
References 18 publications
0
3
0
Order By: Relevance
“…[7][8][9] However, due to the large number of side effects elicited by these pharmaceuticals, patients have increasingly focused their attention on natural remedies. 10 Spirulina, a practically harmless cyanobacterium, has been demonstrated to have marked antioxidant activity in vivo and in vitro. [11][12][13] This is attributed to the synergistic action of its components such as antioxidant pigments, phycobiliproteins, carotenes, vitamins C and E, c-linolenic acid, and phenolic compounds.…”
Section: Introduction Imentioning
confidence: 99%
“…[7][8][9] However, due to the large number of side effects elicited by these pharmaceuticals, patients have increasingly focused their attention on natural remedies. 10 Spirulina, a practically harmless cyanobacterium, has been demonstrated to have marked antioxidant activity in vivo and in vitro. [11][12][13] This is attributed to the synergistic action of its components such as antioxidant pigments, phycobiliproteins, carotenes, vitamins C and E, c-linolenic acid, and phenolic compounds.…”
Section: Introduction Imentioning
confidence: 99%
“…49 Real-life studies and Registries have confirmed these data. 50,55 With regard to infections, RCTs and observational studies reported a good safety profile of TNFi. However, even if well tolerated, TNFi are associated with an increased infective risk, including opportunistic infections.…”
Section: Tnf-inhibitorsmentioning
confidence: 99%
“…In fact, the primary treatment involves the use of a combination of non-steroidal anti-inflammatory drugs, glucocorticosteroids, disease-modifying antirheumatic drugs, and biological therapies such as rituximab and infliximab [9]. This therapeutic approach is lengthy and focuses on inhibiting main mediators of the chronic inflammation process to regulate or reduce their degenerative impact on joint tissues [10]. Although these medications are effective, their long-term use in treating chronic inflammation is associated with undesirable side effects.…”
Section: Introductionmentioning
confidence: 99%